Tandem

At Tandem Diabetes Care, we envision a future where diabetes management is seamlessly integrated into daily life through innovative technology that redefines the treatment experience. Our mission is to ease the burden of insulin therapy and improve outcomes by delivering advanced, user-friendly insulin delivery systems powered by breakthrough automated technologies.

We are harnessing predictive algorithms, smart design, and clinical rigor to transform how people living with diabetes interact with their care. By pioneering automated insulin delivery systems such as Control-IQ+, we are creating devices that adapt intuitively to individual needs, empowering patients and healthcare providers alike.

Tandem Diabetes Care is dedicated to advancing the future of diabetes treatment through continual innovation and strategic partnerships, building a world where technology enables healthier lives and greater freedom for those managing diabetes every day.

We've been tracking Tandem Diabetes Care since they shook up the insulin pump market, and honestly, they've impressed us more than we expected. This isn't your typical medical device company that treats patients like an afterthought—they actually seem to get what it's like to live with diabetes.

What caught our attention first was their origin story. Back in 2006, a group of engineers looked at the clunky insulin pumps on the market and basically said, "We can do better." They spent serious time talking to over 4,000 pump users and healthcare providers before building anything. That's the kind of research-first approach we love to see.

The Tech That Actually Makes Sense

Their t:slim X2 pump is where things get interesting. Instead of the usual medical device interface that feels like it's from 2005, you get a color touchscreen that actually responds like your smartphone. The Control-IQ+ technology is doing some clever predictive work—it's not just reacting to blood sugar changes, it's trying to prevent them.

We're particularly excited about their Tandem Mobi system. It's compact enough that you can wear it almost anywhere, and the smartphone control means you're not fumbling with a separate device all the time. For people who want diabetes management to fit their lifestyle instead of dominating it, this feels like a game-changer.

What Sets Them Apart

Here's what we find most impressive: Tandem is the only company with clinical trial data showing their automated insulin delivery system works for type 2 diabetes patients, not just type 1. That's a much bigger market, and frankly, a more complex challenge to solve.

Their partnership strategy is smart too. Instead of trying to build everything in-house, they're working with established players like Dexcom and Abbott for continuous glucose monitoring. That means better integration and fewer headaches for users who want best-in-class components working together seamlessly.

Who Should Pay Attention

If you're someone who's frustrated with outdated pump interfaces or you're tired of diabetes management feeling like a full-time job, Tandem deserves a serious look. Their user-centric design philosophy isn't just marketing speak—it shows up in the actual products.

We're also keeping an eye on their pipeline. The Sigi rechargeable patch pump and their work toward fully closed-loop systems suggest they're not resting on their current success. For a publicly traded company (TNDM), they're taking the right kinds of calculated risks to stay ahead of the curve.